Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.

International journal of molecular sciences - 8 Feb 2023

Gabbia Daniela, De Martin Sara

Abstract excerpt

Hepatocellular carcinoma (HCC), the primary hepatic malignancy, represents the second-highest cause of cancer-related death worldwide. Many efforts have been devoted to finding novel biomarkers for predicting both patients' survival and the outcome of pharmacological treatments, with a particular focus on immunotherapy. In this regard, recent studies have focused on unravelling the role of tumor mutational burden...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cancer Genomics and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Hepatocellular

Share to Ferroptosis and cancer prognosis

Share to Hepatocellular Carcinoma Treatment and Prognosis

Share to Immunotherapy

Share to Liver Neoplasms

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 36834851
DOI: 10.3390/ijms24043441
PMCID: PMC9960420

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.PMID 36834851Read ↗

Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era.Semantic proximity Read ↗

Advances in molecular classification and precision oncology in hepatocellular carcinoma.Semantic proximity Read ↗

Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden.Semantic proximity Read ↗

Expert consensus on the detection and clinical application of tumor mutational burden.Semantic proximity Read ↗

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinomaSemantic proximity Read ↗

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNASemantic proximity Read ↗

Hepatocellular carcinoma: old friends and new tricksSemantic proximity Read ↗

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinomaSemantic proximity Read ↗

The mutational landscape of hepatocellular carcinoma.Semantic proximity Read ↗

Advances in targeted therapies for hepatocellular carcinoma in the genomic era.Semantic proximity Read ↗

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.Semantic proximity Read ↗

Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges AheadSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.